Navigation Links
Protherics Licenses its CoVaccine HT Adjuvant to Nobilon for Influenza Vaccine Indications
Date:9/25/2007

BOXMEER, The Netherlands and LONDON, September 26 /PRNewswire/ -- Nobilon International B.V., part of Organon, the human health care business unit of Akzo Nobel, and Protherics PLC, the international biopharmaceutical company focused on critical care and cancer, today announced that Nobilon has licensed Protherics' CoVaccine HT(TM) adjuvant for use in pandemic influenza vaccines, and seasonal influenza vaccines in elderly people.

More than 300 million doses of seasonal influenza vaccine are produced each year globally, leaving a considerable shortfall in the event of a pandemic influenza outbreak. A powerful adjuvant, such as CoVaccine(TM), may reduce the amount of antigen required in a pandemic influenza vaccine, enabling rapid, large scale production in the event of a pandemic influenza outbreak and for planned stockpiling. In addition, the CoVaccine HT(TM) adjuvant may increase the potency of a seasonal influenza vaccine for elderly people, with impaired immune systems.

The licensing agreement gives Nobilon the exclusive, global rights excluding the US, to develop, manufacture and commercialize two new influenza vaccines containing CoVaccine HT(TM). Protherics will receive an upfront payment from Nobilon on signing the agreement. Protherics is also entitled to receive success related milestone payments and royalty payments on net sales by Nobilon.

Also announced today, Nobilon and a consortium of leading European vaccine experts has received a EUR3.5 million grant to help fund the development of a pandemic influenza vaccine containing CoVaccine HT(TM).

Han van den Bosch, director Research and Development of Nobilon commented: "We are delighted to have gained exclusive access to CoVaccine HT, a promising new adjuvant from Protherics, for use in our flu vaccines. The very encouraging results in preclinical experiments using Nobilon's influenza antigen produced by cell culture and Protherics' CoVaccine adjuvant, justifies further clini
'/>"/>

SOURCE N.V. Organon
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. GenTel licenses next generation cancer research
2. Third Wave licenses Innogenetics tech to settle lawsuit
3. WARF licenses patents for new glaucoma drug treatment
4. PKWARE Licenses Technology to Expand SecureZIP Standard
5. Mentor Licenses Botulinum From WARF and Plans Wisconsin Manufacturing Facility
6. New Mexico firm to make flu vaccine at Wisconsin BioManufacturing facility
7. Studies Offer New Insight into HIV Vaccine Development
8. ESR1 Gene Expression in Oncology and Metabolic Diseases Using the ASCENTATM System Target Validation and Identification of Novel Disease Indications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... (PRWEB) March 03, 2015 Becht ... today that it has acquired The CECON Group, ... the transaction were not announced. , Becht Engineering ... the energy sector including oil and gas production, ... fossil and nuclear power sectors. The company has ...
(Date:3/3/2015)... 03, 2015 Research and Markets ( ... new report "RNAi - Technologies, Markets and Companies" ... of its ability to silence any gene once the ... research tool to discriminate gene function. After the genome ... to target every gene in the genome and target ...
(Date:3/3/2015)... March 3, 2015 DNA Diagnostics Center (DDC), one ... world, celebrates its 20 th anniversary today. Headed ... is a consumer services company that focuses on DNA ... 200 associates and generates a significant portion of sales ... countries. Peter Vitulli acknowledges the ...
(Date:3/3/2015)... GlobalStemCellsGroup.com has recruited Mario Camacho ... biomedical researcher and founding partner of Criogenix SA de ... biomedical professors who will teach the “Diplomat in Cell ... CV is a private company registered in the National ... Mexico (RENIECYT). , Camacho Alcocer will teach two-day, interactive ...
Breaking Biology Technology:Global RNAi Market Report 2015 - Technologies, Markets and Companies 2014-2024 2Global RNAi Market Report 2015 - Technologies, Markets and Companies 2014-2024 3DNA Diagnostics Center, One of The World's Largest DNA Testing Labs, Celebrates Their 20th Anniversary 2DNA Diagnostics Center, One of The World's Largest DNA Testing Labs, Celebrates Their 20th Anniversary 3Mario Camacho Alcocer Joins Global Stem Cells Group Faculty 2Mario Camacho Alcocer Joins Global Stem Cells Group Faculty 3
... SOUTH SAN FRANCISCO, Calif., May 28 Exelixis,Inc. (Nasdaq: ... in,conjunction with the 44th Annual Meeting of the American Society ... on Monday, June 2,2008., Participants: -- George ... Michael M. Morrissey, PhD, President of Research and Development ...
... internationally funded training programmes in biotechnology and biosafety ... are unprepared to effectively manage and monitor the ... open to serious biosafety threats. , The report, ... Studies, says training and management deficiencies in most ...
... Yale and the Institute of Quantum Electronics at ETH ... better understand and predict the properties of both conventional ... Science. , The lasers that most people are familiar ... fixed direction that has a well-defined wavelength and a ...
Cached Biology Technology:REMINDER: Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO 2REMINDER: Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO 3REMINDER: Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO 4Most developing countries ill-equipped to ensure global biosafety: UN University 2Most developing countries ill-equipped to ensure global biosafety: UN University 3New unifying theory of lasers advanced by physicists 2
(Date:2/5/2015)... PARK, North Carolina , 5. Februar ... 35. Jahr als spezialisiertes Logistikunternehmen und hat ... als einzige klinische Logistikfirma (Clinical Logistics Organization ... Kernbotschaft der neuen Kampagne lautet First ... Lieferungen. Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
(Date:2/5/2015)... 28, 2015 New Market Research ... Segment Forecasts To 2020 has Been Added to GrandViewReseach.com ... is expected to reach USD 5.10 billion by 2020, ... Inc. IR cameras help identify the site of tissue ... witness surging demand in medical imaging applications. They have ...
(Date:1/22/2015)... DUBLIN , Jan. 22, 2015 Research and Markets ... "Biometrics - A Global Market Overview" report to ... biometrics technology is to ensure that an individual is who ... technology may make use of a person,s unique physical characteristics, ...
Breaking Biology News(10 mins):Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
... Network and University of Toronto have identified a small ... with chronic Hepatitis C will be able to respond ... the basis of a simple new test in the ... , The study, published in the May issue of ...
... researcher who is now a chief of an immunology laboratory ... boat in the past few years for the experts in ... has developed the "danger model," suggesting that the immune system ... a biological cell's death than with the introduction of foreign ...
... successful in identifying compounds that show potential to overcome ... the key to the more effective and efficient development ... found. , In order to better identify compounds that ... Gregory Weiss and Allison Olszewski employed this virus, called ...
Cached Biology News:Identification of specific genes predicts which patients will respond to Hepatitis C treatment 2Identification of specific genes predicts which patients will respond to Hepatitis C treatment 3Researchers seek to discover what really happens when a virus enters the body 2Researchers seek to discover what really happens when a virus enters the body 3Harmless virus may hold key to more effective HIV drug discovery 2
... BioChain's monkey normal multiple tissue panels ... cellular localization of genes or proteins ... Tissues are mounted on positively charged ... are available in the identical format, ...
Total Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available....
Total Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available....
... T2-02 diaphragm pump features T Squareds patented ... remarkable performance and efficiency. With the most ... T2-02 is ideal for use in portable ... size, long life, and high efficiency. , ...
Biology Products: